CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
Endoscopic subureteric injectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00815334
NCT00815334N/ACompleted
CompareCT.gov

Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance

Samsung Medical Center·interventional·Posted Dec 30, 2008·Updated Jun 17, 2009

In Brief

A clinical study evaluating Endoscopic subureteric injection for Vesicoureteral Reflux. Completed, enrolled 47 participants across 1 site.

Detailed Summary

Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVesicoureteral Reflux
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 30, 2008
Enrollment StartOct 1, 2008
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.5 years ago

Interventions

Endoscopic subureteric injectionprocedure

Endoscopic subureteric injection for the treatment of vesicoureteral reflux using variable materials (polydimethylsiloxane, collagen, and dextranomer/hyaluronic acid copolymer)